Covered recipient · General Payments record
BRYAN E MARTIN
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$977.28
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $218.65 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $52.37 | 3 |
| Astellas Pharma US Inc | $32.70 | 2 |
| EISAI INC. | $20.77 | 1 |
| Incyte Corporation | $18.71 | 1 |
| Janssen Biotech, Inc. | $18.55 | 1 |
| Gilead Sciences, Inc. | $16.56 | 1 |
| Alnylam Pharmaceuticals Inc. | $15.98 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.87 | 1 |
| Celgene Corporation | $14.02 | 1 |
| Regeneron Healthcare Solutions, Inc. | $13.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.09 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972739 | CMS |
| ABBVIE INC. | $14.37 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972741 | CMS |
| ABBVIE INC. | $17.91 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972743 | CMS |
| Alnylam Pharmaceuticals Inc. | $15.98 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125846572 | CMS |
| Astellas Pharma US Inc | $16.82 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139338250 | CMS |
| Astellas Pharma US Inc | $15.88 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139275226 | CMS |
| Celgene Corporation | $14.02 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101143235 | CMS |
| Eisai Inc. | $20.77 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110735061 | CMS |
| Gilead Sciences, Inc. | $16.56 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133831951 | CMS |
| Incyte Corporation | $18.71 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141251946 | CMS |
| Janssen Biotech, Inc. | $18.55 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078814565 | CMS |
| Novartis Pharmaceuticals Corporation | $15.87 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087044228 | CMS |
| Regeneron Healthcare Solutions, Inc. | $13.12 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114109021 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.